1
|
American Diabetes Association: Diagnosis
and classification of diabetes mellitus. Diabetes care. 1 29
Suppl:S43–S48. 2006.
|
2
|
Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen
S and Eizirik DL: Mechanisms of pancreatic beta-cell death in type
1 and type 2 diabetes: Many differences, few similarities.
Diabetes. 2 54 Suppl:S97–S107. 2005. View Article : Google Scholar
|
3
|
Coskun O, Kanter M, Korkmaz A and Oter S:
Quercetin, a flavonoid antioxidant, prevents and protects
streptozotocin-induced oxidative stress and beta-cell damage in rat
pancreas. Pharmacol Res. 51:117–123. 2005. View Article : Google Scholar : PubMed/NCBI
|
4
|
Sato Y, Endo H, Okuyama H, Takeda T,
Iwahashi H, Imagawa A, Yamagata K, Shimomura I and Inoue M:
Cellular hypoxia of pancreatic beta-cells due to high levels of
oxygen consumption for insulin secretion in vitro. J Biol Chem.
286:12524–12532. 2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Lim M, Park L, Shin G, Hong H, Kang I and
Park Y: Induction of apoptosis of Beta cells of the pancreas by
advanced glycation end-products, important mediators of chronic
complications of diabetes mellitus. Ann N Y Acad Sci. 1150:311–315.
2008. View Article : Google Scholar : PubMed/NCBI
|
6
|
Atkinson MA and Eisenbarth GS: Type 1
diabetes: New perspectives on disease pathogenesis and treatment.
Lancet. 358:221–229. 2001. View Article : Google Scholar : PubMed/NCBI
|
7
|
Hsu FL, Liu IM, Kuo DH, Chen WC, Su HC and
Cheng JT: Antihyperglycemic effect of puerarin in
streptozotocin-induced diabetic rats. J Nat Prod. 66:788–792. 2003.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Chen WC, Hayakawa S, Yamamoto T, Su HC,
Liu IM and Cheng JT: Mediation of beta-endorphin by the isoflavone
puerarin to lower plasma glucose in streptozotocin-induced diabetic
rats. Planta Med. 70:113–116. 2004. View Article : Google Scholar : PubMed/NCBI
|
9
|
Liu S, Kilic G, Meyers MS, Navarro G, Wang
Y, Oberholzer J and Mauvais-Jarvis F: Oestrogens improve human
pancreatic islet transplantation in a mouse model of insulin
deficient diabetes. Diabetologia. 56:370–381. 2013. View Article : Google Scholar : PubMed/NCBI
|
10
|
Liu S, Le May C, Wong WP, Ward RD, Clegg
DJ, Marcelli M, Korach KS and Mauvais-Jarvis F: Importance of
extranuclear estrogen receptor-alpha and membrane G protein-coupled
estrogen receptor in pancreatic islet survival. Diabetes.
58:2292–2302. 2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Tiano JP, Delghingaro-Augusto V, Le May C,
Liu S, Kaw MK, Khuder SS, Latour MG, Bhatt SA, Korach KS, Najjar
SM, et al: Estrogen receptor activation reduces lipid synthesis in
pancreatic islets and prevents β cell failure in rodent models of
type 2 diabetes. J Clin Invest. 121:3331–3342. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Malaivijitnond S, Tungmunnithum D,
Gittarasanee S, Kawin K and Limjunyawong N: Puerarin exhibits weak
estrogenic activity in female rats. Fitoterapia. 81:569–576. 2010.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Hwang YP, Kim HG, Hien TT, Jeong MH, Jeong
TC and Jeong HG: Puerarin activates endothelial nitric oxide
synthase through estrogen receptor-dependent PI3-kinase and
calcium-dependent AMP-activated protein kinase. Toxicol Appl
Pharmacol. 257:48–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Wang D, Liu Y, Han J, Zai D, Ji M, Cheng
W, Xu L, Yang L, He M, Ni J, et al: Puerarin suppresses invasion
and vascularization of endometriosis tissue stimulated by
17β-estradiol. PLoS One. 6:e250112011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Li Z, Shangguan Z, Liu Y, Wang J, Li X,
Yang S and Liu S: Puerarin protects pancreatic β-cell survival via
PI3K/Akt signaling pathway. J Mol Endocrinol. 53:71–79. 2014.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Carlsson PO and Palm F: Oxygen tension in
isolated transplanted rat islets and in islets of rat
whole-pancreas transplants. Transpl Int. 15:581–585. 2002.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Carlsson PO, Liss P, Andersson A and
Jansson L: Measurements of oxygen tension in native and
transplanted rat pancreatic islets. Diabetes. 47:1027–1032. 1998.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Devasagayam TP, Tilak JC, Boloor KK, Sane
KS, Ghaskadbi SS and Lele RD: Free radicals and antioxidants in
human health: Current status and future prospects. J Assoc
Physicians India. 52:794–804. 2004.PubMed/NCBI
|
19
|
Simon H-U, Haj-Yehia A and Levi-Schaffer
F: Role of reactive oxygen species (ROS) in apoptosis induction.
Apoptosis. 5:415–418. 2000. View Article : Google Scholar : PubMed/NCBI
|
20
|
Wiseman H and Halliwell B: Damage to DNA
by reactive oxygen and nitrogen species: Role in inflammatory
disease and progression to cancer. Biochem J. 313:17–29. 1996.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Ballinger SW, Patterson C, Yan CN, Doan R,
Burow DL, Young CG, Yakes FM, Van Houten B, Ballinger CA, Freeman
BA and Runge MS: Hydrogen peroxide-and peroxynitrite-induced
mitochondrial DNA damage and dysfunction in vascular endothelial
and smooth muscle cells. Circ Res. 86:960–966. 2000. View Article : Google Scholar : PubMed/NCBI
|
22
|
Yoshida A: Hemolytic anemia and G6PD
deficiency. Science. 179:532–537. 1973. View Article : Google Scholar : PubMed/NCBI
|
23
|
Köhler E, Barrach H and Neubert D:
Inhibition of NADP dependent oxidoreductases by the
6-aminonicotinamide analogue of NADP. FEBS Lett. 6:225–228. 1970.
View Article : Google Scholar : PubMed/NCBI
|